Mike Hollan

The President plans to sign an executive order on Monday morning to enforce the trade clause.

Proposed cuts to Medicaid could cause serious issues in rural areas of the United States.

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

The company shifted several key presidents to adjust its global priorities.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.

The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.

Pharma companies have opportunities to grow, but they also must plan for a complicated future.

The campaign provides information about early signs of the condition along with treatment information.

ConnectING with Carnie promotes the importance of routine screening and treatment options for the involuntary movement condition.

In the face of potential tariffs, the pharmaceutical industry must find alternative ways to reduce costs.

The company is partnering with McLaren Racing and United Autosports for the event.

The investigation would determine whether excessive imports pose a threat to national security.

The basketball star has a personal history with the medication and the struggles with access to it.

This will bring Regulus’ farabursen into Novartis’ renal disease pipeline.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

The German company will expand its access into the United States through the acquisition.

The famous trees, and the festival associated with their blossoming each spring, is part of a tradition for the global pharmaceutical company.

The emerging biotech scene in Chicago has the potential to develop new treatments and technologies, but funding cuts from the federal government could have significant impact on this.

The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.

Arda Ural discusses the possible impact on how companies plan for growth based on the impact of the tariffs.

The company will be adding a new manufacturing site to its NJ campus for the drug Adstiladrin.

The chaotic tariff situation is forcing pharma companies to prepare for multiple outcomes.

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve certain conditions.

Arda Ural discusses the different ways that companies may change the ways they allocate resources in the current geopolitical climate.

Arda Ural explains how the tariffs will impact profit margins and potentially cause drug shortages.

Lynlee Brown discusses the decisions that companies must make to adjust to the tariffs while also ensuring the ongoing innovation continues.

Ted Sweetser discusses turning information into usable datasets and pulling insights from them.